VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

7 hedge funds and large institutions have $3.8K invested in Viracta Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.85K
2 +$82

Top Sellers

1 -$262K
2 -$46.6K
3 -$46.2K
4
Renaissance Technologies
Renaissance Technologies
New York
-$46.1K
5
BlackRock
BlackRock
New York
-$37.8K